Focus Partners Wealth’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
PVM
NI
Focus Partners Wealth's HCAT Position: Q2 2026 in Review
Focus Partners Wealth sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 12,989 shares — an estimated $17K sold.
Focus Partners Wealth first reported a position in HCAT in Q1 2025 and held it in 5 quarters. The position peaked at $84.9K in Q2 2025. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.
- Focus Partners Wealth reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
- Focus Partners Wealth sold 12,989 Health Catalyst shares in Q2 2026, an estimated $17K.
- Focus Partners Wealth first reported a position in Health Catalyst in Q1 2025 and held it in 5 quarters.
- Focus Partners Wealth's Health Catalyst position peaked at $84.9K in Q2 2025.
- 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.
Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.